Crystal structure of the antimicrobial peptidase lysostaphin from Staphylococcus simulans. (1st August 2014)
- Record Type:
- Journal Article
- Title:
- Crystal structure of the antimicrobial peptidase lysostaphin from Staphylococcus simulans. (1st August 2014)
- Main Title:
- Crystal structure of the antimicrobial peptidase lysostaphin from Staphylococcus simulans
- Authors:
- Sabala, Izabela
Jagielska, Elzbieta
Bardelang, Philip T.
Czapinska, Honorata
Dahms, Sven O.
Sharpe, Jason A.
James, Richard
Than, Manuel E.
Thomas, Neil R.
Bochtler, Matthias - Abstract:
- <abstract abstract-type="main" id="febs12929-abs-0001"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="febs12929-sec-0001" sec-type="section"> <p> <italic>Staphylococcus simulans</italic> biovar <italic>staphylolyticus</italic> lysostaphin efficiently cleaves <italic>Staphylococcus aureus</italic> cell walls. The protein is in late clinical trials as a topical anti‐staphylococcal agent, and can be used to prevent staphylococcal growth on artificial surfaces. Moreover, the gene has been both stably engineered into and virally delivered to mice or livestock to obtain resistance against staphylococci. Here, we report the first crystal structure of mature lysostaphin and two structures of its isolated catalytic domain at 3.5, 1.78 and 1.26 Å resolution, respectively. The structure of the mature active enzyme confirms its expected organization into catalytic and cell‐wall‐targeting domains. It also indicates that the domains are mobile with respect to each other because of the presence of a highly flexible peptide linker. The high‐resolution structures of the catalytic domain provide details of Zn<sup>2+</sup> coordination and may serve as a starting point for the engineering of lysostaphin variants with improved biotechnological characteristics.</p> </sec> <sec id="febs12929-sec-0002" sec-type="section"> <title>Structured digital abstract</title> <p> <list id="febs12929-list-0001" list-type="bullet"> <list-item> <p> <ext-link ext-link-type="uri"<abstract abstract-type="main" id="febs12929-abs-0001"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="febs12929-sec-0001" sec-type="section"> <p> <italic>Staphylococcus simulans</italic> biovar <italic>staphylolyticus</italic> lysostaphin efficiently cleaves <italic>Staphylococcus aureus</italic> cell walls. The protein is in late clinical trials as a topical anti‐staphylococcal agent, and can be used to prevent staphylococcal growth on artificial surfaces. Moreover, the gene has been both stably engineered into and virally delivered to mice or livestock to obtain resistance against staphylococci. Here, we report the first crystal structure of mature lysostaphin and two structures of its isolated catalytic domain at 3.5, 1.78 and 1.26 Å resolution, respectively. The structure of the mature active enzyme confirms its expected organization into catalytic and cell‐wall‐targeting domains. It also indicates that the domains are mobile with respect to each other because of the presence of a highly flexible peptide linker. The high‐resolution structures of the catalytic domain provide details of Zn<sup>2+</sup> coordination and may serve as a starting point for the engineering of lysostaphin variants with improved biotechnological characteristics.</p> </sec> <sec id="febs12929-sec-0002" sec-type="section"> <title>Structured digital abstract</title> <p> <list id="febs12929-list-0001" list-type="bullet"> <list-item> <p> <ext-link ext-link-type="uri" xlink:href="http://www.uniprot.org/uniprot/P10547" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink">lysostaphin</ext-link> by <ext-link ext-link-type="uri" xlink:href="http://www.ebi.ac.uk/ontology-lookup/?termId=MI:0114" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink">x-ray crystallography</ext-link> (<ext-link ext-link-type="uri" xlink:href="http://www.ebi.ac.uk/intact/interaction/EBI-9632634" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink">1</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://www.ebi.ac.uk/intact/interaction/EBI-9632614" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink">2</ext-link>).</p> </list-item> </list> </p> </sec> </abstract> … (more)
- Is Part Of:
- FEBS journal. Volume 281:Number 18(2014)
- Journal:
- FEBS journal
- Issue:
- Volume 281:Number 18(2014)
- Issue Display:
- Volume 281, Issue 18 (2014)
- Year:
- 2014
- Volume:
- 281
- Issue:
- 18
- Issue Sort Value:
- 2014-0281-0018-0000
- Page Start:
- 4112
- Page End:
- 4122
- Publication Date:
- 2014-08-01
- Subjects:
- Biochemistry -- Periodicals
Molecular biology -- Periodicals
Pathology, Molecular -- Periodicals
572 - Journal URLs:
- http://firstsearch.oclc.org ↗
http://gateway.ovid.com/ovidweb.cgi?T=JS&MODE=ovid&NEWS=n&PAGE=toc&D=ovft&AN=01038983-000000000-00000 ↗
http://www.blackwell-synergy.com/servlet/useragent?func=showIssues&code=ejb ↗
http://onlinelibrary.wiley.com/ ↗
http://www.blackwell-synergy.com/servlet/useragent?func=showIssues&code=ejb ↗ - DOI:
- 10.1111/febs.12929 ↗
- Languages:
- English
- ISSNs:
- 1742-464X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3901.578500
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3566.xml